Association of Thyrotropin Suppression With Survival Outcomes in Patients With Intermediate- and High-Risk Differentiated Thyroid Cancer

IMPORTANCE: Suppression of thyrotropin (often referred to as thyroid-stimulating hormone, or TSH) with levothyroxine used in management of intermediate- and high-risk differentiated thyroid cancer (DTC) to reduce the likelihood of progression and death is based on conflicting evidence. OBJECTIVE: To...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Netw Open
Autores principales: Klubo-Gwiezdzinska, Joanna, Auh, Sungyoung, Gershengorn, Marvin, Daley, Brianna, Bikas, Athanasios, Burman, Kenneth, Wartofsky, Leonard, Urken, Mark, Dewey, Eliza, Smallridge, Robert, Chindris, Ana-Maria, Kebebew, Electron
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2019
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6484595/
https://ncbi.nlm.nih.gov/pubmed/30707227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.7754
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares